1. Home
  2. VNRX vs IPSC Comparison

VNRX vs IPSC Comparison

Compare VNRX & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.30

Market Cap

40.8M

Sector

Health Care

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.53

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
IPSC
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.8M
47.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VNRX
IPSC
Price
$0.30
$0.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$3.17
$3.00
AVG Volume (30 Days)
2.5M
1.1M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,472,007.00
$113,337,000.00
Revenue This Year
$324.32
$1,589.94
Revenue Next Year
$247.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.48
4122.69
52 Week Low
$0.29
$0.34
52 Week High
$0.94
$1.83

Technical Indicators

Market Signals
Indicator
VNRX
IPSC
Relative Strength Index (RSI) 32.33 47.22
Support Level $0.29 $0.46
Resistance Level $0.33 $0.56
Average True Range (ATR) 0.03 0.04
MACD 0.00 0.00
Stochastic Oscillator 7.66 61.00

Price Performance

Historical Comparison
VNRX
IPSC

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: